Indapamide

Specifications

26807-65-8CAS Number

248-012-7EC Number

4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamideIUPAC Name

C16H16ClN3O3SChemical Formula

365.8 g/molMolecular Weight

indapamide; 26807-65-8; Veroxil; Indamol; Noranat; Fludex; Lozol; Tertensif; Arifon; Indaflex; Ipamix; Tandix; Bajaten; Natrilix; Damide; Indapamida; Metindamide; Natrix; flupamid; indamide; Indapamidum; SE-1520; Fludin; Lorvas; S-1520; FLUBEST; DTXSID7044633; SE 1520; 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide; 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide; Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-; NSC-757075; 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide; Ethibide xl; Natrilix sr; Cardide sr; Indipam xl; Mapemid xl; Tensaid xl; KYD-041; Varbim xl; Rawel xl; Nindaxa 2.5; Opumide 2.5; Indaxa 2.5; F089I0511L; CHEBI:5893; DTXCID5024633; S1520; SE1520; RefChem:58774; S 1520; C03BA11; 4-Chloro-N-((2RS)-2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide; 248-012-7; Pressurai; Indapamidum [INN-Latin]; Indapamida [INN-Spanish]; 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; Indapamide (Lozol); 3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide; N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; MFCD00079375; Cormil; RAC INDAPAMIDE; MLS000028554; BENZAMIDE, 4-CHLORO-N-(2-METHYL-1-INDOLINYL)-3-SULFAMOYL-; NCGC00018172-03; SMR000058829; 4-CHLORO-N-(2-METHYLINDOLIN-1-YL)-3-SULFAMOYLBENZAMIDE; RHC 2555; USV 2555; Natrix (TN); Lozol (TN); SR-01000003079; EINECS 248-012-7; BRN 1604026; Indapamide CRS; UNII-F089I0511L; 26807-65-8(free base); Hypen SR; Racemi c indapamide; Indapamide [USAN:USP:INN:BAN:JAN]; Indapamide (Standard); Spectrum_000917; INDAPAMIDE [MI]; Opera_ID_110; INDAPAMIDE [INN]; INDAPAMIDE [JAN]; Prestwick3_000220; Spectrum2_000980; Spectrum3_000467; Spectrum4_000017; Spectrum5_000866; INDAPAMIDE [USAN]; INDAPAMIDE [VANDF]; CHEMBL406; Indapamide (JP18/USP); INDAPAMIDE [MART.]; INDAPAMIDE [USP-RS]; INDAPAMIDE [WHO-DD]; SCHEMBL41303; Widaplik component Indapamide; BSPBio_000239; BSPBio_002174; KBioGR_000393; KBioSS_001397; 5-20-06-00348 (Beilstein Handbook Reference); MLS001148152; MLS002222229; MLS006011900; orb134441; DivK1c_000508; SPECTRUM1500349; SPBio_001019; BPBio1_000263; BR-1015 component Indapamide; GTPL7203; Indapamide - Bio-X trade mark; INDAPAMIDE [ORANGE BOOK]; SCHEMBL29372690; SCHEMBL29377544; BDBM25901; HMS501J10; HY-B0259R; KBio1_000508; KBio2_001397; KBio2_003965; KBio2_006533; KBio3_001394; 4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide; INDAPAMIDE [EP MONOGRAPH]; Indapamide component of br-1015; NINDS_000508; HMS1920F19; HMS2090M16; HMS2091N07; HMS2095L21; HMS2231G13; HMS3259C14; HMS3369J20; HMS3655E06; HMS3712L21; HMS3748K05; HMS5079N18; INDAPAMIDE [USP MONOGRAPH]; Pharmakon1600-01500349; Indapamide 1.0 mg/ml in Methanol; HY-B0259; MSK10493; Tox21_110775; Tox21_113182; Tox21_302687; CCG-40198; EBC-06876; NSC757075; s1730; STL257105; 3-(Aminosulfonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide; AKOS015888148; Tox21_110775_1; AB03037; AC-2073; DB00808; FI01202; KS-5219; NC00568; NSC 757075; Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-l-yl)-; IDI1_000508; NCGC00018172-02; NCGC00018172-04; NCGC00018172-06; NCGC00018172-08; NCGC00018172-09; NCGC00018172-15; NCGC00089727-02; NCGC00089727-03; NCGC00256884-01; BI300090; SBI-0051415.P003; DB-047020; AB00052021; I0730; I5414; NS00000696; ST51015024; SW198686-2; D00345; EN300-117260; AB00052021-14; AB00052021-15; AB00052021_16; AB00052021_17; Indapamide, analytical standard, for drug analysis; Q1078392; SR-01000003079-2; SR-01000003079-3; BRD-A95869247-001-04-6; BRD-A95869247-001-14-5; BRD-A95869247-001-25-1; BRD-A95869247-001-26-9; Z1501485351; Indapamide, British Pharmacopoeia (BP) Reference Standard; Indapamide, European Pharmacopoeia (EP) Reference Standard; (4-chloro-3-sulfamoylphenyl)-N-(2-methylindolinyl)carboxamide; Indapamide, United States Pharmacopeia (USP) Reference Standard; 3-aminosulfonyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide; 4-chloro-3-aminosulphonyl-N-(2,3-dihydro2-methyl-1H-indol-1-yl)benzamide; Indapamide, Pharmaceutical Secondary Standard; Certified Reference Material; 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1--yl)benzamide; 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamideSynonyms